Department of Nephrology and Clinical Transplantation, Institute of Kidney Diseases and Research Center, Dr. HL Trivedi Institute of Transplantation Sciences (IKDRC-ITS), Civil Hospital Campus, Asarwa, Ahmedabad, 380016, Gujarat, India.
Int Urol Nephrol. 2013 Aug;45(4):1171-8. doi: 10.1007/s11255-012-0323-9. Epub 2012 Nov 8.
Economic constraints in operating an effective maintenance dialysis program leaves renal transplantation as the only viable option for end-stage renal disease patients in India. Kidney paired donation (KPD) is a rapidly growing modality for facilitating living donor (LD) transplantation for patients who are incompatible with their healthy, willing LD.
The aim of our study was to report a single-center feasibilities and outcomes of KPD transplantation between 2000 and 2012. We performed KPD transplants in 70 recipients to avoid blood group incompatibility (n = 56) or to avoid a positive crossmatch (n = 14).
Over a mean follow-up of 2.72 ± 2.96 years, one-, five- and ten-year patient survival were 94.6, 81, 81 %, and death-censored graft survival was 96.4, 90.2, 90.2 %, respectively. Ten percent of patients were lost, mainly due to infections (n = 4). There was 14.2 % biopsy-proven acute rejection, and 5.7 % interstitial fibrosis with tubular atrophy eventually leading to graft loss.
The incidences of acute rejection, patient/graft survival rates were acceptable in our KPD program and, therefore, we believe it should be encouraged. These findings are valuable for encouraging participation of KPD pairs and transplant centers in national KPD program. It should be promoted in centers with low-deceased donor transplantation. Our study findings are relevant in the context of Indian government amending the Transplantation of Human Organs Act to encourage national KPD program. To our knowledge, it is largest single-center report from India.
在印度,运营有效的维持性透析计划的经济限制使得肾移植成为终末期肾病患者的唯一可行选择。肾配对捐赠(KPD)是一种快速发展的模式,可促进与健康、愿意的供体不相容的患者进行活体供体(LD)移植。
我们研究的目的是报告 2000 年至 2012 年间单中心 KPD 移植的可行性和结果。我们对 70 名受者进行了 KPD 移植,以避免血型不合(n = 56)或避免交叉配型阳性(n = 14)。
在平均 2.72±2.96 年的随访中,患者 1、5 和 10 年的存活率分别为 94.6%、81%和 81%,受者死亡的移植物存活率分别为 96.4%、90.2%和 90.2%。10%的患者失访,主要是由于感染(n = 4)。有 14.2%的患者发生了活检证实的急性排斥反应,5.7%的患者发生了间质性纤维化伴肾小管萎缩,最终导致移植物丢失。
我们的 KPD 计划中急性排斥反应的发生率、患者/移植物存活率均在可接受范围内,因此我们认为应鼓励 KPD 计划。这些发现对于鼓励 KPD 配对和移植中心参与国家 KPD 计划具有重要价值。它应该在低死亡供体移植中心推广。我们的研究结果在印度政府修订《人体器官移植法》以鼓励国家 KPD 计划的背景下具有相关性。据我们所知,这是印度最大的单中心报告。